Capricor Therapeutics, Inc. (CAPR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Capricor Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -12.77x | -12.01x | -5.88x | -3.27x | -3.38x | -3.91x |
| P/B Ratio | 4.39x | 3.34x | 5.79x | 8.04x | 2.16x | 1.89x |
| P/S Ratio | 0.00x | 21.82x | 5.20x | 37.15x | 276.24x | 172.15x |
| Profitability | ||||||
| Gross Margin | 0.0% | -124.4% | -44.8% | -755.1% | 100.0% | 100.0% |
| Operating Margin | 0.0% | -191.1% | -95.6% | -1163.9% | -8549.9% | -4412.6% |
| Net Margin | 0.0% | -181.7% | -88.5% | -1137.4% | -8175.9% | -4401.9% |
| EBITDA Margin | 0.0% | -184.7% | -91.4% | -1143.0% | -8449.5% | -4366.2% |
| Liquidity | ||||||
| Current Ratio | 9.01x | 7.77x | 1.63x | 1.82x | 8.82x | 11.33x |
| Quick Ratio | 9.01x | 7.77x | 1.63x | 1.82x | 8.82x | 11.33x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.01x | 0.10x | 0.22x | 0.09x | 0.01x |
YoY = year-over-year change. Source: FMP..